Skip to content

Repligen Corp

RGEN Nasdaq SEC CIK 730272

Follow Repligen Weekly email: filings, results, news

News

1 story filed under Repligen

Repligen CEO Loeillot sells $2.46m in shares

Markets 5 h ago 3 sources

Next results

OCT28

2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: Waltham, MA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Latest filings

Q2 2026 report10-Q · 29 Jul 2026
Q1 2026 report10-Q · 6 May 2026
FY 2025 report10-K · 26 Feb 2026
Q3 2025 report10-Q · 4 Nov 2025
Q2 2025 report10-Q · 7 Aug 2025

Peers

Where this page comes from

Profile · SEC EDGAR

Financials · SEC EDGAR filing dates

Next results · estimated from the filing cadence (SEC EDGAR)

News · 1 story clustered from the RSS aggregator